Anand Sampath, EVP, Operations & Clinical Research at MASIMO CORP (MASI), sold 45,000 shares at $265.58 ($12.0M) on 2020-12-15, disclosed to the SEC on 2020-12-17.
Open-market sale of $12.0M MASI by EVP, Operations & Clinical Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $265.58 | 15,000 | $4.0M | 33.3% |
| 2 | $265.58 | 15,000 | $4.0M | 33.3% |
| 3 | $265.61 | 15,000 | $4.0M | 33.3% |
| Total | $265.59 avg | 45,000 | $12.0M | 100% |
| Filing → |
| MASI | SELL | 2019-11-21 | $2.3M | — | Filing → |
| MASI | SELL | 2019-06-18 | $4.3M | — | Filing → |
| MASI | SELL | 2019-01-16 | $3.5M | — | Filing → |